000 | 01926 a2200565 4500 | ||
---|---|---|---|
005 | 20250518090315.0 | ||
264 | 0 | _c20200924 | |
008 | 202009s 0 0 eng d | ||
022 | _a1347-5215 | ||
024 | 7 |
_a10.1248/bpb.b19-00702 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHaruna, Miya | |
245 | 0 | 0 |
_aDocetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer. _h[electronic resource] |
260 |
_bBiological & pharmaceutical bulletin _c2020 |
||
300 |
_a399-403 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aA549 Cells |
650 | 0 | 4 | _aAntineoplastic Agents |
650 | 0 | 4 |
_aCD11 Antigens _xmetabolism |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aChemokines _xmetabolism |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aCytokines _xmetabolism |
650 | 0 | 4 |
_aDocetaxel _xpharmacology |
650 | 0 | 4 |
_aEpidermal Growth Factor _xantagonists & inhibitors |
650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHMGB1 Protein _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntegrin alpha Chains _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProtein-Tyrosine Kinases _xantagonists & inhibitors |
650 | 0 | 4 |
_aTranscriptional Activation _xdrug effects |
700 | 1 | _aHirata, Michinari | |
700 | 1 | _aIwahori, Kota | |
700 | 1 | _aKanazawa, Takayuki | |
700 | 1 | _aYamamoto, Yoko | |
700 | 1 | _aGoto, Kumiko | |
700 | 1 | _aKawashima, Atsunari | |
700 | 1 | _aMorimoto-Okazawa, Akiko | |
700 | 1 | _aFunaki, Soichiro | |
700 | 1 | _aShintani, Yasushi | |
700 | 1 | _aKumanogoh, Atsushi | |
700 | 1 | _aWada, Hisashi | |
773 | 0 |
_tBiological & pharmaceutical bulletin _gvol. 43 _gno. 3 _gp. 399-403 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1248/bpb.b19-00702 _zAvailable from publisher's website |
999 |
_c30689856 _d30689856 |